FDA inspection
Zhejiang Huahai Pharmaceutical: FDA inspection ending Jul 29, 2021
FDA inspection 1150702 · No Action Indicated (NAI) · Linhai
Key facts
| Inspection ID | 1150702 |
|---|---|
| Firm | Zhejiang Huahai Pharmaceutical |
| FEI number | 3003885745 |
| Address | Coastal Industrial Zone, Chuannan No. 1 Branch No. 9, Donghai 5th Avenue |
| City | Linhai |
| Country | China |
| Fiscal year | 2021 |
| Inspection end date | Jul 29, 2021 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data